A recap of the top videos and podcasts from Contemporary OB/GYN in September 2026, featuring expert interviews on salpingectomy, testosterone evidence, and more.
|Podcasts|September 16, 2020
S2E3: Providing quality care for transgender and nonbinary patients
Author(s)Lindsey Carr, Editor
Halley Crissman, MD, MPH, and Daphna Stroumsa, MD, MPH, MSC, discuss ways in which ob/gyns can provide high-quality care for transgender and nonbinary people assigned female sex at birth.
Advertisement
Watch the
Read the peer-reviewed feature article, '
Learn
Improve your care with training modules:
Advertisement
Related to this article
A recap of the top headlines from Contemporary OB/GYN in September 2026, spanning ACOG's respiratory vaccine guidance to the launch of the Missed & Dismissed podcast.
Experts discuss common patient concerns about vaccination in pregnancy and strategies to improve uptake.
Experts discuss how obstetric and pediatric clinicians can coordinate to protect newborns.
Experts review ACOG's 2026-27 guidance and the RSV window extension for pregnant and postpartum patients.
On September 9, 2026, certolizumab pegol received FDA Breakthrough Therapy Designation for APS pregnancy; Jane E. Salmon, MD, reviews the IMPACT trial results behind it.
Garima Sharma, MD, outlines validated cardiac risk scores for antenatal screening and the postpartum transitions needed to keep high-risk patients from being lost to follow-up.
Anti-CGRP antibody exposure in early pregnancy was linked to higher spontaneous abortion risk; propranolol was not.
Advertisement
Advertisement